Home › Job titles › Bioinformatician I
Bioinformatician I: H-1B salaries
46 labor condition applications used the job title Bioinformatician I. Median offered base salary $78,000; middle half $73,694–$82,533.
Applications (LCAs)46
Median offered salary$78,000
Middle half of salaries$73,694–$82,533
10th–90th percentile$56,884–$86,586
Employers
| Employer | LCAs | Median salary |
|---|---|---|
| Icahn School of Medicine at Mount Sinai | 16 | $79,500 |
| Duke University | 7 | $84,406 |
| The University of Alabama at Birmingham | 5 | $77,976 |
| Beth Israel Deaconess Medical Center, Inc. | 4 | $55,237 |
| Brigham and Women's Hospital | 3 | $65,000 |
| Benaroya Research Institute at Virginia Mason | 2 | $85,798 |
| Benaroya Research Institute | 2 | $86,651 |
| ASRT, Inc. | 2 | $74,500 |
| Duke University Health System | 2 | $82,504 |
| University of Mississippi Medical Center | 1 | $53,150 |
| The Jackson Laboratory | 1 | $63,744 |
| General Hospital Corporation | 1 | $75,275 |
By wage level
| Wage level | Median salary |
|---|---|
| Level I (entry) | $77,976 |
| Level II (qualified) | $82,533 |
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
By fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 12 | $77,568 |
| FY2024 | 13 | $75,705 |
| FY2025 | 13 | $82,000 |
| FY2026 | 7 | $82,867 |
Cities
- New York, NY15
- Boston, MA8
- Durham, NC6
- Birmingham, AL4
- Seattle, WA2
- Ann Arbor, MI1
- Jackson, MS1
- Philadelphia, PA1
- Feasterville-Trevose, PA1
- Fairfax, VA1
- Savage, MN1
- Bar Harbor, ME1
- Houston, TX1
- Atlanta, GA1
- Cary, NC1
- Raleigh, NC1
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).